JB Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Buy |
5,579
+393
| +8% | +$18.2K | 0.01% | 214 |
|
|
2025
Q1 | $316K | Sell |
5,186
-479
| -8% | -$29.2K | 0.02% | 180 |
|
|
2024
Q4 | $320K | Sell |
5,665
-29
| -0.5% | -$1.64K | 0.02% | 178 |
|
|
2024
Q3 | $295K | Sell |
5,694
-6
| -0.1% | -$310 | 0.02% | 183 |
|
|
2024
Q2 | $237K | Sell |
5,700
-40
| -0.7% | -$1.66K | 0.01% | 208 |
|
|
2024
Q1 | $311K | Sell |
5,740
-1,165
| -17% | -$63.2K | 0.02% | 180 |
|
|
2023
Q4 | $354K | Buy |
6,905
+140
| +2% | +$7.18K | 0.03% | 158 |
|
|
2023
Q3 | $393K | Sell |
6,765
-115
| -2% | -$6.67K | 0.03% | 129 |
|
|
2023
Q2 | $440K | Sell |
6,880
-77
| -1% | -$4.93K | 0.04% | 116 |
|
|
2023
Q1 | $482K | Buy |
6,957
+434
| +7% | +$30.1K | 0.04% | 110 |
|
|
2022
Q4 | $469K | Buy |
6,523
+29
| +0.4% | +$2.09K | 0.05% | 109 |
|
|
2022
Q3 | $462K | Sell |
6,494
-258
| -4% | -$18.4K | 0.05% | 105 |
|
|
2022
Q2 | $520K | Buy |
6,752
+27
| +0.4% | +$2.08K | 0.06% | 152 |
|
|
2022
Q1 | $492K | Buy |
6,725
+351
| +6% | +$25.7K | 0.05% | 167 |
|
|
2021
Q4 | $397K | Sell |
6,374
-302
| -5% | -$18.8K | 0.04% | 183 |
|
|
2021
Q3 | $395K | Buy |
+6,676
| New | +$395K | 0.05% | 189 |
|